商誉减值
Search documents
天奇股份:2025年全年净利润预计同比扭亏
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-28 11:07
Core Viewpoint - Tianqi Co., Ltd. is expected to turn a profit in 2025, with a projected net profit attributable to shareholders ranging from 45 million to 65 million yuan, marking a year-on-year turnaround [1] Group 1: Financial Performance - The company anticipates a significant increase in net profit excluding non-recurring gains and losses, projected to be between -95 million and -65 million yuan, representing a year-on-year growth of 67.51% to 77.77% [1] - The overall performance during the reporting period is attributed to improved profitability in its two main businesses: intelligent equipment and lithium battery recycling [1] Group 2: Business Segments - Intelligent Equipment Business: The company has a robust order backlog, with significant growth in overseas markets and steady progress in domestic projects, leading to stable revenue and profit growth [1] - Lithium Battery Recycling Business: Despite challenges in raw material supply and lower-than-expected shipment volumes, the business saw a turnaround in gross margin due to improved capacity utilization and rising cobalt prices [1] - Circular Equipment Business: Revenue from this segment declined due to a sluggish scrap steel market, resulting in significant losses [1] Group 3: Impairment and Investment Losses - Goodwill Impairment: The company is assessing potential impairment of goodwill related to its acquisition of Jiangxi Tianqi Jintai Co., Ltd., with the final impairment amount pending audit results [1] - Investment Losses: The company expects to recognize investment losses in its associate, Wuxi Youqi Intelligent Technology Co., Ltd., estimated between 25 million and 30 million yuan due to ongoing R&D investments [1] Group 4: Non-Operating Gains and Losses - Non-operating gains and losses for the reporting period are estimated to be around 13 million to 14 million yuan, primarily from the disposal of equity interests in associates and long-term assets [1]
华宝国际:华宝股份预计年度归母净利润为6500-9500万 同比扭亏为盈
智通财经网· 2026-01-28 10:42
Core Viewpoint - Huabao International (00336) reported that its subsidiary, Huabao Flavors & Fragrances Co., Ltd. (300741.SZ), is expected to achieve a net profit of 65-95 million for the fiscal year ending December 31, 2025, compared to a loss of approximately 296 million in the previous year [2] Financial Performance - The net profit attributable to Huabao Flavors' shareholders is projected to be between 65 million and 95 million, a significant recovery from a loss of about 296 million in the same period last year [2] - The net profit after deducting non-recurring gains and losses is also expected to be between 65 million and 95 million, compared to a loss of approximately 386 million in the previous year [2] Operational Insights - During the reporting period, Huabao Flavors turned its net profit around, indicating a positive shift in financial health [2] - The losses in 2024 were primarily due to impairment losses on goodwill related to the edible flavor and tobacco flavor asset group [2] - For 2025, the overall operational situation of Huabao Flavors is expected to remain stable, with orderly development of its main business and continuous optimization of internal management [2] - Management's preliminary assessment indicates that there is no significant risk of further impairment of goodwill as of December 31, 2025 [2]
三诺生物:预计2025年净利润同比下降60.92%-73.95%
Xin Lang Cai Jing· 2026-01-28 10:36
三诺生物公告,预计2025年度净利润为8500万元至1.27亿元,同比下降60.92%-73.95%。预计扣除非经 常性损益后的净利润为4500万元至6750万元,同比下降77.09%-84.73%。2025年度,公司全资子公司 PTS公司经营业绩未达预期,预计计提商誉减值1.3亿元至1.7亿元。同时,公司美国子公司THI与罗氏达 成和解,预计影响净利润7463万元。产品结构变化和市场费用增加也对公司业绩产生影响。 ...
华平股份:预计2025年全年净亏损1.61亿元—2.25亿元
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-28 10:28
南财智讯1月28日电,华平股份发布年度业绩预告,预计2025年全年归属于上市公司股东的净利润为亏 损1.61亿元至2.25亿元;预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为亏损1.66 亿元至2.31亿元。业绩变动原因说明:(1)报告期末,公司聘请了评估机构,对公司收购郑州新益华 医学科技有限公司、郑州新益华信息科技有限公司(以下简称"新益华医学"、"新益华信息")所形成的 商誉进行了初步评估和测算。结合行业发展环境、市场趋势及实际经营状况等综合因素分析,判断新益 华医学和新益华信息所形成的商誉出现减值迹象。为更加客观、公正地反映公司的财务状况和资产价 值,公司根据财政部《企业会计准则第8号—资产减值》、中国证监会《会计监管风险提示第8号—商誉 减值》及公司内部政策等相关规定,本着谨慎性原则,预计对新益华医学和新益华信息资产组所形成的 合并商誉计提减值准备金额为5,336万元至6,935万元之间。最终计提商誉减值准备金额将以评估机构正 式出具的商誉减值测试评估报告及会计师事务所审计结果为准。(2)报告期末,公司根据财政部《企 业会计准则第8号—资产减值》,按照谨慎性原则,结合市场行情及公司 ...
佛山照明:预计2025年净利润同比下降50.02%-59.66%
Xin Lang Cai Jing· 2026-01-28 10:20
佛山照明公告,预计2025年度净利润为1.8亿元-2.23亿元,同比下降50.02%-59.66%。受全球宏观经济环 境影响,照明行业市场需求不振,同时铜、铝、锡等大宗商品价格大幅上涨,导致部分原材料价格快速 上涨,折旧费用增加,压缩了公司利润空间。公司控股子公司佛山市国星光电股份有限公司经营业绩不 及预期,预计对因收购国星光电股权形成的商誉计提减值约3000万元-5000万元。 ...
华宝国际(00336)发盈警 预期2025年度取得税前亏损2.63亿元至3.43亿元 同比减少约15%至35%
智通财经网· 2026-01-28 10:17
智通财经APP讯,华宝国际(00336)发布公告,本集团预期于本年度(截至2025年12月31日止年度)将取得 税前亏损介乎人民币2.63亿元至人民币3.43亿元(包括商誉以及其他资产的减值计提及其他计提),与去 年同期的税前亏损约人民币4.02亿元相比,预期亏损减少约15%至35%。 嘉豪食品主要于中国从事调味品生産、销售、营销及分销。本集团考虑到未来中国餐饮业仍然低迷,以 及嘉豪食品于2025年的收入及营运盈利未如管理层于本公司2024年12月31日的预期,基于审慎及适用的 会计原则,本集团对嘉豪食品的未来销售采取审慎的预测,因而作出以上商誉减值估算。该商誉减值属 初步评估,且不排除会作出修改。 本年度税前亏损主要由于:本公司以及其附属公司层面的股份为基础的薪酬开支约人民币0.98亿元;及 本公司调味品板块旗下的嘉豪食品有限公司及其附属公司(嘉豪食品)所属现金产生单位的商誉减值亏 损,预计介乎人民币4.7亿元至人民币5.3亿元。 ...
鹏翎股份年度业绩转亏出资0.8亿认购基金 负债率上升盈利能力大幅下滑
Xin Lang Cai Jing· 2026-01-28 10:02
日前,鹏翎股份公告称,为实现公司战略规划,加快战略布局落地,提高公司资产价值,公司拟与关联 方荣成市康禧水产有限公司、广发信德投资管理有限公司共同出资2亿元人民币,设立荣成市鹏翎广发 信德机器人创业投资合伙企业(有限合伙)(拟定名,最终以市场监督管理部门登记为准)。其中,公 司作为有限合伙人拟以自有资金认缴出资8000万元人民币。 盈利能力下滑伴随着公司偿债能力的变化。2025年第三季度,鹏翎股份的资产负债率达到38.12%,明 显高于去年同期的29.95%,增幅显著。 事实上,盈利能力下降的趋势在中报中已初现端倪。2025年上半年,公司毛利率为19.53%,同比下降 5.29%;净利率更是大幅下滑65.24%,仅为2.04%。面对主业盈利能力下滑,鹏翎股份将如何应对成为 投资者关注的焦点。 鹏翎股份面临的不仅是财务数据的波动,更深层次的结构性问题逐渐浮现。 在第三季度财报中,公司详细解释的利润下滑五大原因中,毛利率下降被列在首位,其次为政府补助减 少、资金收益降低且融资成本攀升等因素。这些挑战,正是鹏翎股份在汽车零部件行业激烈竞争中必须 面对的现实。 最新发布的财务数据显示,2025年前三季度,公司前三季度 ...
家联科技:预计2025年净利润为-5200万元至-6900万元
Xin Lang Cai Jing· 2026-01-28 09:41
Core Viewpoint - The company anticipates a negative net profit for the fiscal year 2025, projecting a loss between 69 million to 52 million yuan, a significant decline from a profit of 57 million yuan in the same period last year [1] Financial Performance - The expected net profit after deducting non-recurring gains and losses is projected to be between -210 million to -160 million yuan, compared to a profit of 12.53 million yuan in the previous year [1] - Both the net profit attributable to shareholders and the net profit after deducting non-recurring gains and losses are expected to be negative and show a considerable decrease compared to the previous year [1] Operational Challenges - The primary reason for the anticipated losses is the strategic optimization of the global supply chain to address the complex international trade environment, which has led to simultaneous construction and adjustment of production capacities across multiple locations [1] - New production bases are currently in the capacity construction and ramp-up phase, resulting in low overall capacity utilization, which has caused manufacturing and management costs to remain high, leading to a significant increase in unit manufacturing costs [1] Financial Costs - The issuance of convertible bonds has resulted in increased interest expenses, contributing to a rise in financial costs compared to the previous year [1] Impairment Concerns - The company has preliminarily assessed that the goodwill arising from the acquisition of Zhejiang Jiadebao Technology Co., Ltd. and Sumter Easy Home, LLC may be impaired due to their operational performance and development not meeting expectations [1]
德新科技(603032.SH)发预盈,预计2025年度归母净利润3800万元到4900万元
智通财经网· 2026-01-28 09:20
Core Viewpoint - DeXin Technology (603032.SH) is expected to achieve a net profit attributable to shareholders of the parent company ranging from 38 million to 49 million yuan for the fiscal year 2025, marking a turnaround from loss to profit compared to the previous year [1] Group 1 - For the fiscal year 2024, the company has made a provision for goodwill impairment amounting to 164.2968 million yuan based on goodwill impairment testing results [1] - Preliminary calculations for the fiscal year 2025 indicate that there will be no significant goodwill impairment, positively impacting the current period's profit [1]
中国中药:2025年亏损净额预估约为3.5亿元至5亿元
Cai Jing Wang· 2026-01-28 06:37
近日,中国中药发布公告称,预计2025年本集团将由盈转亏,亏损净额区间预估约为3.5亿元至5亿元, 而上年同期的盈利净额约为2077万元。同时,本期经调整盈利净额预计同比下降45%至55%,上年同期 约为6.36亿元。 董事会表示,上述事项不会对本集团的持续经营能力产生不利影响,并强调所提及的经调整盈利净额并 未在香港财务报告准则中界定。股东及潜在投资者应注意本公告所载信息为初步评估,最终业绩公告预 计于2026年3月底前发布。 亏损的主要原因包括中药配方颗粒业务收入规模及盈利能力下降。此外,本期商誉减值、无形资产减值 及信用减值增加。 (中国中药公告) (编辑:杨燕 林辰) ...